Assura (LON:AGR) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Assura Plc (LON:AGRGet Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 47.90 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares traded.

Analysts Set New Price Targets

AGR has been the topic of several research reports. Peel Hunt restated a “buy” rating and issued a GBX 60 price target on shares of Assura in a research note on Tuesday, September 30th. Shore Capital reiterated a “hold” rating on shares of Assura in a research note on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 60.

Read Our Latest Stock Report on AGR

Assura Trading Up 0.4%

The stock has a market capitalization of £1.54 billion, a P/E ratio of 895.85, a P/E/G ratio of 3.60 and a beta of 0.37. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The business has a 50-day moving average price of GBX 47.48 and a two-hundred day moving average price of GBX 47.90.

Assura Company Profile

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Further Reading

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.